Essentra plc has signed an agreement to acquire Clondalkin Group’s Specialist Packaging Division for a cash consideration of approximately US$455m. This transaction – which is expected to complete in Q1 2015 and represents Essentra’s largest acquisition to date – significantly extends the company’s existing packaging capabilities and creates a global value proposition to serve its customers.
With 24 strategically located facilities, Clondalkin SPD is a leading global provider of a broad suite of speciality secondary packaging solutions for the pharmaceutical and health & personal care industries, and will transform Essentra’s position in these end-markets.
As a leading player in North America, and with strong market positions in Europe, Clondalkin SPD’s range of technologies and capabilities support the high product quality and the versatility to deliver the complex solutions required.
Commenting on the acquisition, Malcolm Waugh, Essentra Group Commercial Director, stated: “Clondalkin SPD is a highly attractive business, with a focus on the growing health and personal care industries, and a comprehensive offering of high quality, innovative and mission critical products to meet the exacting requirements of an international customer base, which is increasingly seeking a global partner for their packaging solutions.”
